Notifying physicians were asked to provide a chest radiograph taken in the period extending from six weeks before to four weeks after the start of treatment. Radiographs were not available for 90 (5 5%) subjects and these were excluded from further study. At independent assessment by a consultant radiologist 324 radiographs from the remaining subjects were judged not to show evidence of pulmonary tuberculosis; 302 (88%) of these showed only enlarged nodes or pulmonary effusions, and the remainder were either normal (32, 10%) or not assessable (6, 2%). These 324 subjects were excluded from analysis. Of the remaining 1229 subjects, seven were resident abroad at the time of notification and were also excluded, leaving 1222 cases for analysis; these represent 93% of those notified as having pulmonary tuberculosis who were found to have a pulmonary lesion at independent radiographic assessment.
Over the past decade more than 3500 cases of pulmonary tuberculosis in England Deaths in adults with notified pulmonary tuberculosis 1983-5 only 50 (17%) cases of Indian subcontinent ethnic origin. Seven hundred and eighty seven (64%) of all the patients were men and 658 (54%) were white men. Of the 1222 patients, 158 (12-9%) were reported to have died before completion of chemotherapy; death certificates were obtained for 132 (88%). In 69 (50%) of these 132 cases tuberculosis was mentioned in part 1 of the death certificate and in 43 (31 %) in part 2. Sixty five (5 %) patients defaulted or emigrated before completion ofchemotherapy and their outcome is unknown. Case fatality rates by age, sex, and racial origin are displayed in table 1; in both sexes rates rose with increasing age. Of the 158 deaths, 124 (78%) occurred in male patients, almost of all them white; male case fatality within each age group was consistently higher than female. The overall number of deaths in patients of Indian subcontinent origin was small (6% of all deaths), and a smaller proportion died than of white patients, but the trends of increasing case fatality with age and ofhigher rates in men than women cases were also present.
To assess the effect of disease severity, case fatality rates by radiographic extent of disease were calculated (see table 2 ). In all age and sex groups fatality rates rose with increasing extent of disease. Rates were particularly high (over 50%) in elderly patients with disease affecting an equivalent of three lung zones or more. With a few exceptions (where the numbers were small) male rates were higher than female in each category and in each age group. 
STANDARDISED RATES
The numbers of observed deaths in the group studied were compared with the number of deaths expected from the all causes age and sex standardised national mortality rates. Overall, observed deaths were 10 times higher than those expected. Ratios of observed to expected deaths are displayed by age and severity in table 3. Ratios rose consistently with increasing extent of disease. In both sexes and within each category of severity the ratios fell with increasing age.
TIME OF DEATH
Twenty one patients died before starting chemotherapy; 66 (48%) of the remaining 137 deaths occurred within four weeks of the start of treatment (data not tabulated). In the first two months after the start of chemotherapy the weekly death rates for patients over 65 years of age were at least five times as high as those for younger patients, but after the 10th week the rates were much lower and alike in the two groups. Similarly, when patients with more than one lung zone affected were compared with those with less extensive disease, the weekly death rates in the first two months of treatment were very much higher in those with more widespread disease.
LOGISTIC REGRESSION ANALYSIS
Logistic regression analysis of four clinical variables confirmed increasing age and radiographic evidence of extensive disease (p < 0-01 for each) and to a lesser extent male sex (p = 0-06) as important independent risk factors for death during chemotherapy. Racial origin was not an independent risk factor of significance (p = 0-09). The regression coefficients derived from this analysis were used to model the probability of death during chemotherapy for hypothetical patients of various ages and with different severities of disease. These probabilities are shown in of notified cases was excluded from analysis because suitable radiographs were not available. The age distributions showed that these patients were slightly older than the remaining subjects and their exclusion means that the reported case fatality may be an underestimate, though the effect is likely to be slight. The loss to follow up a small number of subjects may also have produced a small bias. This study, which compared the mortality of patients with pulmonary tuberculosis with that of the general population, shows a considerably greater all cause mortality than expected. As the socioeconomic distribution of people with tuberculosis is likely to be di-fferent from that of the general population and as mortality rates were not adjusted for socioeconomic group, the excess mortality reported here may be an overstimate. The higher standardised mortality ratio in young patients, particularly women and those with extensive disease, reflects the fewer conflicting causes of death in young people.
No attempt was made to study the effects of different treatment regimens but the preponderance of deaths occurring soon after the start of chemotherapy is consistent with observations in earlier case series. 
